Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With Osteoarthritis: A Cross-over, Cluster Randomized Controlled, Non-inferiority Trial Based on National Quality Databases. ProHipQ-OA

NCT05530551 is registered in ClinicalTrials.gov with Soren Overgaard as lead sponsor.

NCT NCT05530551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05530551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With Osteoarthritis: A Cross-over, Cluster Randomized Controlled, Non-inferiority Trial Based on National Quality Databases. ProHipQ-OA
Lead sponsor
Soren Overgaard
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2022
Completion date
September 1, 2025
Enrollment
20,000 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, hip, prosthetic-joint infection, total hip arthroplasty